STOCKHOLM

Celebian Launches Innovative Subscription Service for TikTok Likes and Views

Retrieved on: 
Monday, February 12, 2024

Stockholm, Sweden--(Newsfile Corp. - February 12, 2024) - Celebian has officially unveiled its latest offering: a cutting-edge subscription service dedicated to providing TikTok users with automatic likes and views.

Key Points: 
  • Stockholm, Sweden--(Newsfile Corp. - February 12, 2024) - Celebian has officially unveiled its latest offering: a cutting-edge subscription service dedicated to providing TikTok users with automatic likes and views.
  • With the digital space becoming increasingly competitive, Celebian recognizes the importance of standing out on popular platforms like TikTok.
  • The service is available through two distinct but equally valuable offerings: Automatic TikTok Likes and the Automatic TikTok Views subscriptions.
  • For more information about Celebian's TikTok likes and views subscription service, visit the website .

ASM Global Secures Major Naming Rights Deal for Sweden’s National Soccer Stadium to Be Known as Strawberry Arena

Retrieved on: 
Monday, January 15, 2024

ASM Global today announced a new naming rights partnership with Strawberry Hotel Group beginning in July which will rename the former Friends Arena in Stockholm – a mainstay of major live entertainment experiences – to Strawberry Arena.

Key Points: 
  • ASM Global today announced a new naming rights partnership with Strawberry Hotel Group beginning in July which will rename the former Friends Arena in Stockholm – a mainstay of major live entertainment experiences – to Strawberry Arena.
  • Venue operator ASM Global and new naming rights partner Strawberry – which has over 240 hotels in the region – plan to increase the already market-leading live entertainment experiences to guests, fans, members, customers and artists alike.
  • Petter Stordalen, owner, and founder of Strawberry, said, "The new name, Strawberry Arena, symbolizes experience and diversity, setting the arena as a place for energy, courage and enthusiasm.
  • "In July, the arena will change its name to Strawberry Arena, and this is a major milestone for our group and our history in Sweden.

Mines of Dalarnia Terraformed Update Now Available on Mainnet

Retrieved on: 
Friday, November 17, 2023

Stockholm, Sweden--(Newsfile Corp. - November 17, 2023) - Mines of Dalarnia, an action-adventure blockchain-based gaming platform, proudly announces its highly anticipated Terraformed update.

Key Points: 
  • Stockholm, Sweden--(Newsfile Corp. - November 17, 2023) - Mines of Dalarnia, an action-adventure blockchain-based gaming platform, proudly announces its highly anticipated Terraformed update.
  • Mines of Dalarnia Terraformed Update is now available for download.
  • The recordings are available on Mines of Dalarnia official YouTube channel: New Economy Design Part 1 and New Economy Design Part 2 .
  • As Mines of Dalarnia continues to evolve, to offer more engaging and enriching experiences for its players, the team welcomes feedback and welcomes every action-adventure gamer to join the Mines of Dalarnia community.

Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM

Retrieved on: 
Monday, November 20, 2023

This strategic move will enable Vironova BioAnalytics to enhance its capabilities and continue to deliver TEM analyses according to Good Manufacturing Practices (GMP) for the pharmaceutical industry.

Key Points: 
  • This strategic move will enable Vironova BioAnalytics to enhance its capabilities and continue to deliver TEM analyses according to Good Manufacturing Practices (GMP) for the pharmaceutical industry.
  • Following the completion of the acquisition, the company will be renamed and rebranded as QuTEM.
  • Vironova BioAnalytics has established a strong reputation as a trusted partner for pharmaceutical companies globally, known for its commitment to high-quality standards.
  • For more information about QuTEM (formerly Vironova BioAnalytics) and its TEM services, please visit qutem.com.

Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration

Retrieved on: 
Tuesday, October 10, 2023

The partnership between Salipro Biotech and Icosagen will build on Salipro's track record of establishing multiple collaboration and licensing agreements with leading pharma and biotech companies to enable drug discovery against complex membrane protein targets, ranging from small molecule drug discovery programs to structural biology and antibody discovery.

Key Points: 
  • The partnership between Salipro Biotech and Icosagen will build on Salipro's track record of establishing multiple collaboration and licensing agreements with leading pharma and biotech companies to enable drug discovery against complex membrane protein targets, ranging from small molecule drug discovery programs to structural biology and antibody discovery.
  • We are excited to unlock the potential of these targets with Icosagen and develop novel drugs that can improve patient outcomes," said Jens Frauenfeld, CEO of Salipro Biotech.
  • Their knowledge in antibody discovery, encompassing high-throughput antibody screening and variety of lead optimization techniques will enrich the collaboration and form solid basis for supporting biologic drug developments in the future.
  • Both teams in Icosagen and Salipro Biotech are always finding ways to push the boundaries in novel technologies of biologics development.

Eureka Partners Fortifies Its Stance in Blockchain and Cryptocurrency with $40 Million Investment from Nordic Venture Innovations AB

Retrieved on: 
Monday, September 25, 2023

This strategic investment represents a significant milestone in Eureka Partners' journey and will expedite its growth within the blockchain and cryptocurrency domains, providing additional resources and support for future innovation and ecosystem development.

Key Points: 
  • This strategic investment represents a significant milestone in Eureka Partners' journey and will expedite its growth within the blockchain and cryptocurrency domains, providing additional resources and support for future innovation and ecosystem development.
  • Eureka Partners distinguishes itself with a youthful and dynamic team, a group of individuals primed to adapt swiftly to the rapidly evolving crypto landscape.
  • Proudly, the team at Eureka Partners consists of true crypto natives-individuals who have been deeply immersed in the blockchain and cryptocurrency space since its inception.
  • This substantial investment from Nordic Venture Innovations AB is a resounding vote of confidence in Eureka Partners' vision and capabilities.

Salipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery program

Retrieved on: 
Tuesday, September 12, 2023

STOCKHOLM, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Sumitomo Pharma Co., Ltd. to reveal the mechanism of action and pharmacological characterization of a drug candidate.

Key Points: 
  • The collaboration leverages Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilize a challenging drug target to investigate the pharmacological characteristics of a compound from Sumitomo Pharma’s discovery program.
  • STOCKHOLM, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Sumitomo Pharma Co., Ltd. to reveal the mechanism of action and pharmacological characterization of a drug candidate.
  • Under the terms of the collaboration, Salipro Biotech will utilize its unique expertise in stabilizing challenging membrane proteins such as GPCRs, ion channels and transporters via its proprietary Salipro® technology platform to advance a Sumitomo Pharma’s drug discovery program by characterizing a drug candidate with the desired therapeutic properties against a selected target.
  • “We are excited to be working with Sumitomo Pharma to investigate this drug candidate and its mechanism of action,” said Jens Frauenfeld, CEO of Salipro Biotech.

Introducing Payup: The Ultimate Financial Comparison Site for Swedes

Retrieved on: 
Tuesday, September 5, 2023

Tailored Recommendations: Based on individual user preferences and financial needs, Payup delivers curated recommendations to ensure users get products most suited to them.

Key Points: 
  • Tailored Recommendations: Based on individual user preferences and financial needs, Payup delivers curated recommendations to ensure users get products most suited to them.
  • Expert Insights: Beyond comparison, Payup offers financial literacy tools and articles to help Swedes navigate the world of finance better.
  • Johan Karlsson, Chief Content Editor of Payup, said, "We realized there was a gap in the market for a comprehensive financial comparison tool that is both easy to use and absolutely transparent.
  • We're committed to helping Swedes make smarter financial choices, and this platform is just the beginning."

Celonis Opens New Offices in Denmark and Sweden to Accelerate Value Creation through Process Mining for Customers in the Nordics

Retrieved on: 
Wednesday, August 23, 2023

Celonis , the global leader in Process Mining , today announced the opening of its new offices in Copenhagen, Denmark and Stockholm, Sweden.

Key Points: 
  • Celonis , the global leader in Process Mining , today announced the opening of its new offices in Copenhagen, Denmark and Stockholm, Sweden.
  • The launch of these new sites bolsters Celonis’ existing operations and adoption for its market leading process mining technology in the Nordics.
  • “The new Stockholm and Copenhagen offices are important steps in our mission to bring the value of process mining to customers across all regions and industries,” said Nominacher.
  • “Our strengthened presence in the Nordics enables us to accelerate process mining adoption for enterprises in the Nordics.

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan

Retrieved on: 
Tuesday, June 13, 2023

STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology. The patent, entitled "Saposin lipoprotein particles and libraries from crude membranes," (Japanese Patent No. 7149929) further strengthens Salipro Biotech's leading position in the field of membrane protein research and drug discovery.

Key Points: 
  • Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs, SLCs and Ion Channels.
  • STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology.
  • "This patent grant in Japan is an important addition to our global IP portfolio, which already includes granted patents in the U.S., EU, and China," says Jens Frauenfeld, CEO of Salipro Biotech.
  • By expanding the company's intellectual property portfolio, this patent enhances Salipro Biotech's value proposition for collaborations with pharmaceutical companies and its internal pipeline.